UDI: Value Beyond Compliance
In this informational session, Karen Conway discusses her research with the FDA on value and the UDI. Mike Schiller joins the conversation by adding the actions AHRMM is taking with the Learning UDI Community to identify adoption practices and move beyond compliance.
Related Resources
White Papers
This white paper explores the realities facing healthcare delivery, some of the new models being developed and what they could mean for the s
Letter/Comment
An announcement of the Final Rule issued by the IRS.
Advisory
The final regulations that provide guidance on the excise tax imposed on the sale of certain medical devices, enacted by the Health Care and Educ
Toolkits/Methodology
How-to guide to managing IV disruptions.
Guides/Reports
In 2001 the Institute of Medicine (IOM) published
Letter/Comment
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Fo